# Azure Health Technology Ltd — Form D

Azure Health Technology Ltd of SYDNEY, C3, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-24. The offering totals $353K, of which $353K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-07-24
- Form: D
- Accession: 0001192482-20-000632
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $353K
- Amount sold: $353K
- Investors: 6
- Date of first sale: 2020-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371750

## Issuer

- Name: Azure Health Technology Ltd
- CIK: 0001817595
- Entity type: Other
- Jurisdiction: AUSTRALIA
- Address: C/O MLC CENTRE, SUITE 03, LEVEL 45, SYDNEY, C3, 2000
- Phone: 61 414 906 611

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Andrew David Bristow | Director | Sydney, C3 |
| Louis James Panaccio | Director | Sydney, C3 |
| Gregory Barry Starr | Director | Sydney, C3 |
| Glenn James Tong | Director | Sydney, C3 |
| Jiayi James Yu | Director | Sydney, C3 |
| Catriona Betty Glover | Executive Officer | Sydney, C3 |

## More

- [CIK 1817595 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1817595&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001192482-20-000632.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.